在严重的黄热病感染中,低凝血性与出血有关:来自队列研究的结果
Leticia Lemos Jardim1,2, Mariana Brandão Franco3, Neimy Ramos de Oliveira4
1Instituto René Rachou (Fiocruz Minas), Belo Horizonte, Minas Gerais, Brazil.
Research and practice in thrombosis and haemostasis
|May 31, 2024
概括
严重的黄热病感染会导致由于低凝血性导致出血. 旋转性血栓形成仪 (ROTEM) 确定了延长的凝血时间和降低的α角作为黄热病患者不良结果的预测因素.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 临床病理学 临床病理学
背景情况:
- 严重的黄热病感染 (YFI) 可以导致出血性透析.
- 在YFI中,血液静止的概况很少被报告.
研究的目的:
- 通过旋转血栓电平测量 (ROTEM) 来描述YFI的静血特征.
主要方法:
- 评估了严重YFI的成年患者的临床,实验室和ROTEM参数.
- 与出血和死亡结果相关的ROTEM变量.
主要成果:
- 研究的96%的患者出现出血,18%的患者死亡.
- 与幸存者相比,死亡的患者表现出明显延长的凝血时间 (CT) 和降低的α角.
- 在90%的出血患者中检测到低凝血性.
结论:
- 低凝血性是严重YFI出血透析的一个关键特征.
- 异常的CT和α角值可以作为严重YFI中不良结果的预测指标.
相关概念视频
Disorders of Hemostasis
837
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
837
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K
Coagulation
6.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.2K
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K


